Automated grading of castleman disease histopathology using an attention-based multiple-instance learning model

M Muir Morrison (1University of Utah, Pathology, Salt Lake City, United States) B Brendan O'Fallon (1University of Utah, Pathology, Salt Lake City, United States) A Ashley Hutchings (2ARUP Institute for Research and Innovation, Salt Lake City, United States) M Mark Dewey (2ARUP Institute for Research and Innovation, Salt Lake City, United States) P Paul English (2ARUP Institute for Research and Innovation, Salt Lake City, United States) A Alexandra Rangel (2ARUP Institute for Research and Innovation, Salt Lake City, United States) L Lauren Zuromski (2ARUP Institute for Research and Innovation, Salt Lake City, United States) K Katie Knight (2ARUP Institute for Research and Innovation, Salt Lake City, United States) A Anna Bowen (2ARUP Institute for Research and Innovation, Salt Lake City, United States) K Kiera Kearns (2ARUP Institute for Research and Innovation, Salt Lake City, United States) K Kristin Shaw (2ARUP Institute for Research and Innovation, Salt Lake City, United States) J Janini Sankar (2ARUP Institute for Research and Innovation, Salt Lake City, United States) F Fnu Alnoor (3University of Miami, Pathology, Miami, United States) O Oscar Silva P Peyman Samghabadi (5University of California San Francisco, Pathology, San Francisco, United States) A Archana Agarwal (1University of Utah, Pathology, Salt Lake City, United States) T Timothy Hanley (1University of Utah, Pathology, Salt Lake City, United States) K Kristin Karner (2Institute for Clinical and Experimental Pathology, ARUP Laboratories, Department of Pathology, Salt Lake City, United States) M Madhu Menon (1University of Utah, Pathology, Salt Lake City, United States) R Rodney Miles (4University of Utah, Salt Lake City, United States) J Jay Patel (NanoScience Technology Center, University of Central Florida) A Anna Shestakova (1University of Utah, Pathology, Salt Lake City, United States) P Peng Li N Nicholas Spies (2ARUP Institute for Research and Innovation, Salt Lake City, United States) D David Ng (Synthesis of Macromolecules Max Planck Institute For Polymer Research Mainz Germany) R Robert Ohgami (3ARUP Institute for Research and Innovation, Salt Lake City, United States)

Abstract

Abstract Castleman Disease (CD) is a heterogeneous group of rare lymphoproliferative disorders. The diagnosis requires histopathologic interpretation of lymph node biopsies where five key histologic features (atretic germinal centers, follicular dendritic cell prominence, vascularity, hyperplastic germinal centers, and plasmacytosis) are graded on an ordinal scale from 0 to 3. However, this process is somewhat subjective with variability among pathologists. We evaluated whether AI computational pathology techniques, specifically attention-based multiple instance learning (ABMIL), could automate CD grading reliably and with accuracy comparable to hematopathology experts. We developed a proof-of-concept ABMIL model to predict slide-level CD histology scores from whole-slide images (WSIs) of H&E-stained lymph node tissue. Each WSI was divided into tiles, and a pre-trained foundation model (Virchow2) was used to extract embeddings (numerical representations of the image features). These embeddings were aggregated by the ABMIL model into slide-level predictions across the five established histologic features and additionally, follicular twinning. While not part of the formal CD grading criteria, follicular twinning is a recurrent morphologic finding of interest and was included in our study to evaluate whether the model could detect and score biologically relevant but non-canonical features. Our dataset consisted of 154 WSIs featuring CD or CD-like histology, annotated by a group of eight hematopathologists for each feature. Model training and validation were performed using only slide-level grades. To evaluate model performance and interpretability, we compared model predictions to expert consensus among eight hematopathologists using Krippendorff's alpha. We also compared model predictions against the range of interobserver agreement among expert hematopathologists who were not CD specialists. Leave-one-out analysis of hematopathologist graders confirmed significant inter-rater variability. Importantly, model disagreement was typically less than or equal to the average hematopathologist inter-rater spread: model predictions showed moderate concordance with expert “ground-truth” annotations, as quantified by a Krippendorff's α = 0.59, within the range of inter-rater variability seen among hematopathologists (mean α = 0.51, stddev = 0.22). Visualizations of tile-level attention weights confirmed that the model attends to diagnostically relevant regions and ignores irrelevant regions, supporting biological interpretability despite only using weak supervision. This study demonstrates the feasibility of using ABMIL models to automatically score histologic features in CD with reliability comparable to human experts. The model's interpretability and agreement within the bounds of pathologist variation underscore its potential utility as a diagnostic aid or second reader and support further exploration into hybrid workflows combining human expertise with machine assistance, particularly in grading in rare hematologic diseases where inter-rater variability is a known challenge.

Article Details

Journal Blood
Volume / Issue Vol. 146, Issue Supplement 1
Published November 03, 2025
Pages 3002-3002
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (26)

M

Muir Morrison

1University of Utah, Pathology, Salt Lake City, United States

B

Brendan O'Fallon

1University of Utah, Pathology, Salt Lake City, United States

A

Ashley Hutchings

2ARUP Institute for Research and Innovation, Salt Lake City, United States

M

Mark Dewey

2ARUP Institute for Research and Innovation, Salt Lake City, United States

P

Paul English

2ARUP Institute for Research and Innovation, Salt Lake City, United States

A

Alexandra Rangel

2ARUP Institute for Research and Innovation, Salt Lake City, United States

L

Lauren Zuromski

2ARUP Institute for Research and Innovation, Salt Lake City, United States

K

Katie Knight

2ARUP Institute for Research and Innovation, Salt Lake City, United States

A

Anna Bowen

2ARUP Institute for Research and Innovation, Salt Lake City, United States

K

Kiera Kearns

2ARUP Institute for Research and Innovation, Salt Lake City, United States

K

Kristin Shaw

2ARUP Institute for Research and Innovation, Salt Lake City, United States

J

Janini Sankar

2ARUP Institute for Research and Innovation, Salt Lake City, United States

F

Fnu Alnoor

3University of Miami, Pathology, Miami, United States

O

Oscar Silva

P

Peyman Samghabadi

5University of California San Francisco, Pathology, San Francisco, United States

A

Archana Agarwal

1University of Utah, Pathology, Salt Lake City, United States

T

Timothy Hanley

1University of Utah, Pathology, Salt Lake City, United States

K

Kristin Karner

2Institute for Clinical and Experimental Pathology, ARUP Laboratories, Department of Pathology, Salt Lake City, United States

M

Madhu Menon

1University of Utah, Pathology, Salt Lake City, United States

R

Rodney Miles

4University of Utah, Salt Lake City, United States

J

Jay Patel

NanoScience Technology Center, University of Central Florida

A

Anna Shestakova

1University of Utah, Pathology, Salt Lake City, United States

P

Peng Li

N

Nicholas Spies

2ARUP Institute for Research and Innovation, Salt Lake City, United States

D

David Ng

Synthesis of Macromolecules Max Planck Institute For Polymer Research Mainz Germany

R

Robert Ohgami

3ARUP Institute for Research and Innovation, Salt Lake City, United States